support@nanobiousa.com

1-888-678-8889 (USA)

Columbus Business First

As reported by Columbus Business First on Mar 3rd 2017, Ohio State University is pouring resources into getting its pharmaceutical research on the market – Liaoning Pharma-Union Pharmaceutical Co. Ltd., has open its first U.S. subsidiary on campus with a $1.4 million investment.

Nanobio Delivery Pharmaceutical Co. Ltd., and it's built entirely around a goal to commercialize the research of Peixuan Guo to custom-design and produce nanoparticles of RNA, a type of genetic material. As said by Haibo Hu, Nanobio Devlivery founder and CEO, this company is currently the only one in the world that can supply high-quality RNA nanoparticles as a commercial product for pre-clinical use.

Please see full story here: http://www.bizjournals.com/columbus/news/2017/03/03/ohio-state-picks-drug-commercialization-boss.html
Copyright © Nanobio Delivery Pharmaceutical Co., Ltd. All rights reserved.